Reply to letter to the editor: “Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China”

Detalles Bibliográficos
Autores principales: Cavalcante, Marcelo Borges, Sarno, Manoel, Araujo Júnior, Edward, Da Silva Costa, Fabricio, Barini, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553148/
https://www.ncbi.nlm.nih.gov/pubmed/33051771
http://dx.doi.org/10.1007/s00404-020-05830-w
_version_ 1783593545111699456
author Cavalcante, Marcelo Borges
Sarno, Manoel
Araujo Júnior, Edward
Da Silva Costa, Fabricio
Barini, Ricardo
author_facet Cavalcante, Marcelo Borges
Sarno, Manoel
Araujo Júnior, Edward
Da Silva Costa, Fabricio
Barini, Ricardo
author_sort Cavalcante, Marcelo Borges
collection PubMed
description
format Online
Article
Text
id pubmed-7553148
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-75531482020-10-14 Reply to letter to the editor: “Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China” Cavalcante, Marcelo Borges Sarno, Manoel Araujo Júnior, Edward Da Silva Costa, Fabricio Barini, Ricardo Arch Gynecol Obstet Correspondence Springer Berlin Heidelberg 2020-10-13 2021 /pmc/articles/PMC7553148/ /pubmed/33051771 http://dx.doi.org/10.1007/s00404-020-05830-w Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Correspondence
Cavalcante, Marcelo Borges
Sarno, Manoel
Araujo Júnior, Edward
Da Silva Costa, Fabricio
Barini, Ricardo
Reply to letter to the editor: “Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China”
title Reply to letter to the editor: “Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China”
title_full Reply to letter to the editor: “Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China”
title_fullStr Reply to letter to the editor: “Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China”
title_full_unstemmed Reply to letter to the editor: “Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China”
title_short Reply to letter to the editor: “Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China”
title_sort reply to letter to the editor: “safety of lymphocytes immunotherapy during the covid-19 outbreak in wuhan, china”
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553148/
https://www.ncbi.nlm.nih.gov/pubmed/33051771
http://dx.doi.org/10.1007/s00404-020-05830-w
work_keys_str_mv AT cavalcantemarceloborges replytolettertotheeditorsafetyoflymphocytesimmunotherapyduringthecovid19outbreakinwuhanchina
AT sarnomanoel replytolettertotheeditorsafetyoflymphocytesimmunotherapyduringthecovid19outbreakinwuhanchina
AT araujojunioredward replytolettertotheeditorsafetyoflymphocytesimmunotherapyduringthecovid19outbreakinwuhanchina
AT dasilvacostafabricio replytolettertotheeditorsafetyoflymphocytesimmunotherapyduringthecovid19outbreakinwuhanchina
AT bariniricardo replytolettertotheeditorsafetyoflymphocytesimmunotherapyduringthecovid19outbreakinwuhanchina

Ejemplares similares